United Digestive acquires Florida GI group | Ingestible sensor to detect GI disorders
Ingestible sensor could help doctors pinpoint GI difficulties (MIT News)
The sensor sends out its location as it moves through the GI tract, revealing where slowdowns in digestion may occur.
United Digestive Acquires GGN and GEC, Strengthening Its Position as a Leader in GI Care (PR Newswire)
This is the third Florida-based group to join United Digestive and represents the company’s first acquisition of 2023.
How to ‘see through the hype’: 6 hospital digital, GI leaders on AI’s potential for gastroenterology (Becker’s GI & Endoscopy)
AI is becoming increasingly common is gastroenterology, where devices that learn from millions of previous images are being used in colonoscopies to detect polyps that might have otherwise been missed.
PitchBook: After a hot 2022, PE healthcare deals expected to decline in coming months. But a rebound is possible (Fierce Healthcare)
Looking ahead to 2023, deal volumes may decline in the first half of the year with an increasingly tough fundraising environment and diminishing capital to allocate.
Rev up your practice’s revenue (Physicians Practice)
The article offers revenue-enhancing initiatives that have proven successful in other medical groups and should be on your radar right now.
Tips for Maximizing Colonoscopy Preps (Medscape)
Dr. David Johnson shares some simple strategies for improving your patients’ experience around the aspect of colonoscopy that they often dread the most.
Dxcover Raises $11.9M to Advance Liquid Biopsy Platform (Photonics)
Glasgow-based startup Dxcover has raised $11.9 million in series A and grant financing to support the development of its platform for the detection of early-stage cancers, including brain and colorectal cancers.
NIH awards $2.9M grant to study genetic cause of IBD in Hispanic patients (Healio)
Researchers at University of Miami Miller School of Medicine were awarded a $2.9 million grant by the NIH to study the genetic data of more than 3,000 Hispanic individuals.
How to Best Treat Underserved IBD Patients (TIME)
The article highlights solutions that can help fill existing care gaps and ensure that underserved patient populations are better cared for in the future.
Largest gastroenterology groups by number of physicians (Becker’s GI & Endoscopy)
As the gastroenterology industry continues to consolidate, more physicians are opting to join management service organizations.
After Positive Stool Test, Colonoscopy Should Look Closely for Serrated Polyps (GI & Endoscopy News)
Clinically important serrated polyps are more likely to be detected on follow-up colonoscopy in patients who had a positive multi-target stool DNA test than in those who had a positive FIT or a colonoscopy without either test beforehand.
American Gastroenterological Association announces 2023 Recognition Awards recipients (EurekAlert)
The AGA has announced the 2023 recipients of its annual recognition prizes, given in honor of outstanding contributions and achievements in gastroenterology.
Exercise training reduces liver fat in patients with NAFLD, even without weight loss (MDedge)
Exercise training is 3.5 times more likely to result in a clinically meaningful response in liver fat, compared with standard clinical care.
Key Insights on Endoscopic Strictures in Crohn’s Disease (GI Insights)
Dr. Neil Nandi speaks with one of the guideline authors, Dr. Gursimran Kochhar from the Allegheny Health Network in Pittsburgh, Pennsylvania, to better understand how to manage these strictures.
Which Moves Should Providers Watch From Amazon, CVS & Walgreens This Year? (MedCity News)
A recent report from the American Hospital Association outlines major moves the healthcare industry should be watching this year from disruptors like Amazon, CVS and Walgreens.
5 AI Tools That Could Help Build A Medical Practice (The Medical Futurist)
What AI tools are of your assistance? The Medical Futurist offers a list of solutions anyone can use focusing on algorithms not strictly connected to medicine.
Rise Therapeutics Announces FDA Clearance of its IND Application to Initiate a Phase 1 Study of an Oral Immunotherapy for the Treatment of Ulcerative Colitis (PR Newswire)
R-3750 is a synthetic biology-based cellular immunotherapy being developed for the treatment of Inflammatory Bowel Disease (IBD).
Gastroparesis Referrals Often Based on Misdiagnosis (Medscape)
Most patients referred to tertiary care with suspected gastroparesis (GP) actually have a different condition, usually functional dyspepsia (FD), a new retrospective review suggests.